After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Anavex Life Sciences Corp.
A small group of Alzheimer's patients treated with Anavex 2-73 are exhibiting signs of memory loss, faltering cognition and inability to take care of themselves over time.
These stocks look ready to break out and trade higher from current levels.
Too many investors have a fundamental misunderstanding about the significance of orphan drug designation. I should say, insignificance, because the FDA delineation, on its own, means very little.
Stocks edge higher on Friday afternoon as crude oil continues to race toward the $40 level.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.